Zdrowie i gospodarka · 15/06/2018
FDA Releases Draft Guidance on Guidewires for Coronary, Peripheral, and Neurovascular Use
The FDA is releasing a draft guidance document outlining recommended testing and labeling for guidewires intended for use in coronary, peripheral, and neurovascular procedures, and is seeking feedback from industry and FDA staff.
Source: Federal Register — Food and Drug AdministrationOpen original release →